The effect of infliximab on chemokines in patients with rheumatoid arthritis
โ Scribed by Eiji Torikai; Yasunori Kageyama; Motohiro Suzuki; Tetsuya Ichikawa; Akira Nagano
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 179 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0770-3198
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
In patients with rheumatoid arthritis (RA) a decrease in the terminal galactose content of N-linked glycans of the Fc region of agalactosyl immunoglobulin G (IgG) (G0) occurs. The aim of this study was to evaluate, for the first time, the effect of infliximab, a new monoclonal antibody for the treat
## Abstract ## Objective According to the Centers for Disease Control and Prevention, the 1999 and 2000 incidence rates for tuberculosis (TB) in the US population were 6.4 and 5.8, respectively, per 100,000 persons. Recently, reports of TB following infliximab administration have raised questions